Expertise in
4
conditions

Dean A. Fennell

Lancaster Road, 
Leicester, ENG, GB 
Expertise in
4
conditions
Lancaster Road, 
Leicester, ENG, GB 

Overview

Dean Fennell practices practicing medicine in Leicester, United Kingdom.

Mr. Fennell is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Metastases.

He is actively involved in clinical research, co-authoring 130 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Lancaster Road, Leicester, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Mesothelioma Stratified Therapy (MiST): A Stratified Multi-arm Phase IIa Clinical Trial to Enable Accelerated Evaluation of Targeted Therapies for Relapsed Malignant Mesothelioma
Mesothelioma Stratified Therapy (MiST): A Stratified Multi-arm Phase IIa Clinical Trial to Enable Accelerated Evaluation of Targeted Therapies for Relapsed Malignant Mesothelioma
Enrollment Status: Completed
Publish Date: August 17, 2026
Intervention Type: Drug
Study Drugs: Rucaparib, Abemaciclib, Pembrolizumab+Bemcentinib, Atezolizumab+Bevacizumab, Dostarlimab+Niraparib
Study Phase: Phase 2
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)
Enrollment Status: Active_not_recruiting
Publish Date: May 04, 2026
National Lung Matrix Trial: Multi-drug, Genetic Marker-directed, Non-comparative, Multi-centre, Multi-arm Phase II Trial in Non-small Cell Lung Cancer
National Lung Matrix Trial: Multi-drug, Genetic Marker-directed, Non-comparative, Multi-centre, Multi-arm Phase II Trial in Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: April 28, 2026
Intervention Type: Drug
Study Drugs: AZD4547, Vistusertib, Palbociclib, Crizotinib, Selumetinib, Docetaxel, AZD5363, Osimertinib, Durvalumab, Sitravatinib, AZD6738
Study Phase: Phase 2
A Randomized, Open-Label Phase II/III Study With Dendritic Cells Loaded With Allogeneic Tumour Cell Lysate (PheraLys) in Subjects With Mesothelioma as Maintenance Treatment (MesoPher) After Chemotherapy
A Randomized, Open-Label Phase II/III Study With Dendritic Cells Loaded With Allogeneic Tumour Cell Lysate (PheraLys) in Subjects With Mesothelioma as Maintenance Treatment (MesoPher) After Chemotherapy
Enrollment Status: Completed
Publish Date: February 01, 2024
Intervention Type: Drug
Study Drug: MesoPher
Study Phase: Phase 2/Phase 3
A Randomised Phase II Trial of Oral Vinorelbine as Second Line Therapy for Patients With Malignant Pleural Mesothelioma
A Randomised Phase II Trial of Oral Vinorelbine as Second Line Therapy for Patients With Malignant Pleural Mesothelioma
Enrollment Status: Completed
Publish Date: October 12, 2021
Intervention Type: Drug, Other
Study Drug: Vinorelbine
Study Phase: Phase 2
View 4 Less Clinical Trials

130 Total Publications

Editorial Expression of Concern: Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo.
Editorial Expression of Concern: Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo.
Journal: Oncogenesis
Published: June 18, 2026

Frequently Asked Questions about Dean A. Fennell

Is Dean A. Fennell a top-rated expert for Mesothelioma?

MediFind is an objective health platform that identifies experts based on real-world data. Dean A. Fennell is classified as an Elite expert for Mesothelioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Dean A. Fennell participate in research or clinical trials?

Yes. Dean A. Fennell has published 130 articles and abstracts on conditions like Mesothelioma. You can view a list of Dean A. Fennell's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Fennell's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile